Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Health Guard Biotechnology's quarterly market cap
declined
from Dec. 2025 (¥2,323.37 Mil) to Mar. 2026 (¥2,064.91 Mil) and
declined
from Mar. 2026 (¥2,064.91 Mil) to Jun. 2026 (¥1,031.05 Mil).
Beijing Health Guard Biotechnology's annual market cap
declined
from Dec. 2023 (¥7,624.71 Mil) to Dec. 2024 (¥4,643.94 Mil) and
declined
from Dec. 2024 (¥4,643.94 Mil) to Dec. 2025 (¥2,323.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beijing Health Guard Biotechnology's Enterprise Value for Today is ¥1,805.97 Mil.
Beijing Health Guard Biotechnology (BJSE:920575) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beijing Health Guard Biotechnology Market Cap Related Terms
Beijing Health Guard Biotechnology Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology Market Cap Chart
BJSE:920575 vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, Beijing Health Guard Biotechnology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Health Guard Biotechnology Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's Market Cap distribution charts can be found below:
* The bar in red indicates where Beijing Health Guard Biotechnology's Market Cap falls into.
Beijing Health Guard Biotechnology Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology (BJSE:920575) has a Market Cap of ¥1,570.46 Mil as of Aug. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Health Guard Biotechnology and its competitors. According to the industry distribution chart, Beijing Health Guard Biotechnology ranks #581 out of 1421 companies in the Biotechnology industry, placing it in the top 40.9%.
Is Beijing Health Guard Biotechnology's Market Cap too high?
Beijing Health Guard Biotechnology's current Market Cap is ¥1,570.46 Mil. Based on the distribution chart, Beijing Health Guard Biotechnology ranks #581 out of 1421 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Health Guard Biotechnology has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Health Guard Biotechnology's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Health Guard Biotechnology ranks #581 out of 1421 companies for Market Cap. This puts Beijing Health Guard Biotechnology in the upper half of its industry. The industry median Market Cap is 123.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 123.29, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Health Guard Biotechnology and its competitors. For the Biotechnology industry, the median Market Cap is 123.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Health Guard Biotechnology's current Market Cap is ¥1,570.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health Guard Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology (BJSE:920575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.92, compared to a current price of ¥5.59 — trading 29.4% below its estimated fair value. The current Market Cap is ¥1,570.46 Mil. Beijing Health Guard Biotechnology's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beijing Health Guard Biotechnology (BJSE:920575), the current Market Cap is ¥1,570.46 Mil as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued.
The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92.
GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.
Key valuation signals for BJSE:920575:
Market Cap: ¥1,570.46 Mil
GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score
Get the complete analysis for BJSE:920575
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920575 has been successfully added to your 
